Recombinant Human SGCa Protein，His & GST

SGCa (Sarcoglycan alpha) is a crucial component of the muscle membrane dystrophin-glycoprotein complex, playing a significant role in stabilizing muscle fibers and facilitating communication between the cytoskeleton and the extracellular matrix. Mutations or deficiencies in SGCa are implicated in various forms of muscular dystrophy, particularly limb-girdle muscular dystrophy (LGMD), leading to progressive muscle weakness and degeneration. The study of SGCa recombinant protein is essential for understanding its structural and functional properties, as well as its interactions within the dystrophin-glycoprotein complex. By exploring the biochemical characteristics of SGCa, researchers aim to elucidate the molecular mechanisms underlying muscle maintenance and pathogenesis in muscular dystrophies. Moreover, this research can pave the way for potential therapeutic strategies, including gene therapy and protein replacement approaches, targeting the restoration of SGCa function in affected muscle tissues. Investigating the folding, stability, and interactions of SGCa at a molecular level provides valuable insights into its role in muscle health and disease, and could lead to advancements in treatment options for patients suffering from SGCa-related myopathies. As such, the recombinant expression and characterization of SGCa are critical for both basic research and the development of novel therapeutic interventions.